3 Japanese AI Stocks With Earnings Growth Over 11%

Global bond yields have surged, with Japan’s 10-year government bond rate touching its highest level since 1996, which raises the price of capital but also rewards businesses that can cut waste and do more with less. That is where Japanese artificial intelligence healthcare stocks come in. This article breaks down three AI driven medical players from our screener that aim to turn cost pressure into potential opportunity.

The three stocks below are just a starter set, and the full screen surfaced 7 more artificial intelligence healthcare players with equally compelling narratives that are not covered here. To identify and analyze the highest conviction ideas straight at the source, head into the Transformative Artificial intelligence (AI) Healthcare Stocks screener.

Chugai Pharmaceutical (TSE:4519)

Overview: Chugai Pharmaceutical is a Japan based drug maker focused on oncology and specialty biologic therapies, increasingly infusing AI into early stage R&D workflows.

Operations: Chugai generates about ¥1.34t from pharmaceuticals, with ¥486,188 million recorded in Japan and the remainder captured in segment adjustments.

Market Cap: ¥10.94t

Chugai Pharmaceutical matters in this AI healthcare screen because it is trying to wire machine intelligence directly into how new medicines are discovered, not just how they are prescribed.

"Phylo and Chugai Pharmaceutical entered a collaboration to use Phylo's Biomni Lab AI platform across Chugai's drug discovery workflows, covering areas such as single cell analysis, human genetics, disease biology, and target evaluation."

What ultimately happens to profitability will depend on how one underlying assumption about future development productivity performs under real world conditions.

That productivity question is the real hinge for Chugai Pharmaceutical, and the full narrative for Chugai Pharmaceutical lays out how AI driven efficiency, capital intensity and risk could be decoupling beneath the surface.

Wellness Communications (TSE:366A)

Overview: Wellness Communications runs cloud health data platforms and services that help employers and medical providers manage checkups, occupational health, and AI driven workforce analytics.

Operations: Wellness Communications generates about ¥13,018 million from Health Check Solutions, ¥1,524 million from Health Management Cloud, and ¥236 million from Medical Institution Support.

Market Cap: ¥14.68 billion

Wellness Communications integrates AI into real world healthcare workflows through Growbase and SUZAKU, connecting medical checkups, health data, and HR decisions into a single analytics layer that can support diagnostics and workplace interventions. Investors tracking the screener theme may focus on how this healthcare data stack scales, while also monitoring how pressure around future monetization develops.

As that monetization question hangs over Wellness Communications, the analysis report for Wellness Communications to see how its AI health data engine stacks up against peers and embedded expectations.

eWeLLLtd (TSE:5038)

Overview: eWeLLLtd runs iBow, a cloud platform that digitizes home nursing records and insurance claims, including an AI home nursing report.

Market Cap: ¥32.21 billion

eWeLLLtd plugs AI into home nursing through its iBow AI home nursing report, turning routine visit notes into structured clinical data that can tighten documentation quality and support care coordination. Recent earnings trends and a premium P/E suggest investors already price in meaningful AI traction, which places significant importance on what happens if a single key assumption changes.

If that key assumption around AI traction shifts, the analysis report for eWeLLLtd could show whether eWeLLLtd’s premium P/E is masking underappreciated strength or brewing downside risk.

Seeking Alternatives Before Momentum Flies

Fresh ideas tend to move first. By the time a breakout is obvious, the ideal entry can be gone. Scan these curated picks while it still matters and consider your options promptly.

• Identify sturdy balance sheets that can handle shocks, then review the curated list of solid balance sheet and fundamentals (21 results) before the strongest options become crowded.
• Explore potential cash-flowing AI opportunities by checking the hand picked 38 profitable AI stocks that aren't just burning cash that are not just chasing headlines.
• Evaluate opportunities ahead of a possible grid upgrade wave by reviewing the focused 39 power grid technology and infrastructure stocks that could benefit if spending accelerates.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com